Bloodstream Infections and Outcomes Following Allogeneic Hematopoietic Cell Transplantation: a Single-Center Study

Allogeneic hematopoietic stem cell transplantation (alloHCT) is used as a potentially curative therapy for patients with high-risk hematological disorders1. However, patients undergoing alloHCT require profound immunosuppression to preserve graft function and to prevent graft-versus-host disease (GVHD), predisposing them to infectious complications that increase morbidity and risk of mortality2 –4.

Source: Biology of Blood and Marrow Transplantation - October 14, 2021 Category: Hematology Authors: Abel Santos Carreira, Maria Queralt Salas, Mats Remberger, Igor Novitzky Basso, Arjun Datt Law, Wilson Lam, Ivan Pasic, Dennis Kim, Fotios V. Michelis, Auro Viswabandya, Armin Gerbitz, Jeffrey Howard Lipton, Shahid Husain, Rajat Kumar, Jonas Mattsson Source Type: research